Macrogenics reported $-24955000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US USD 4.6B 1.31B
Amgen AMGN:US USD 2.74B 562M
AstraZeneca AZN:LN USD 1.25B 706M
Biogen BIIB:US USD 1.32B 1.37B
Bristol Myers Squibb BMY:US USD 2.47B 117M
Daiichi Sankyo 4568:JP JPY 61.2B 26.82B
Eli Lilly And LLY:US USD 1.68B 466.4M
Genmab GEN:DC DKK 1.93B 684M
Geron GERN:US USD -39948000 11.97M
Gilead Sciences GILD:US USD 2.84B 808M
Immunogen IMGN:US USD -77429000 16.38M
Johnson & Johnson JNJ:US USD 4.2B 1.62B
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Macrogenics MGNX:US USD -24955000 16.85M
Merk MRK:US USD 3.99B 939M
Mirati Therapeutics MRTX:US USD -186443000 9.24M
Pfizer PFE:US USD 9.41B 2.69B
Puma Biotechnology PBYI:US USD 2.39M 9.61M
Regeneron Pharmaceuticals REGN:US USD 1.22B 113.8M
Roche Holding ROG:VX 11.55B 3.47B
Seattle Genetics SGEN:US USD -192805000 59.69M
Xencor XNCR:US USD -38348000 10.35M